GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Lhfpl2 | affects expression | EXP | | 6480464 | CTD | bisphenol A affects the expression of LHFPL2 mRNA | PMID:25181051 | Lhfpl2 | decreases expression | EXP | | 6480464 | CTD | bisphenol A results in decreased expression of LHFPL2 mRNA | PMID:30816183 PMID:32528016 PMID:34947998 | Lhfpl2 | increases expression | EXP | | 6480464 | CTD | bisphenol A results in increased expression of LHFPL2 mRNA | PMID:33296240 | Lhfpl2 | increases expression | ISO | LHFPL2 (Homo sapiens) | 6480464 | CTD | bisphenol A results in increased expression of LHFPL2 mRNA | PMID:25047013 PMID:27685785 PMID:29275510 | Lhfpl2 | increases methylation | ISO | LHFPL2 (Homo sapiens) | 6480464 | CTD | bisphenol A results in increased methylation of LHFPL2 gene | PMID:31601247 | Lhfpl2 | multiple interactions | ISO | LHFPL2 (Homo sapiens) | 6480464 | CTD | [bisphenol A co-treated with Fulvestrant] results in increased methylation of LHFPL2 gene; [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of LHFPL2 mRNA | PMID:28628672 PMID:31601247 | |
Go Back to source page | Continue to Ontology report |